These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37937301)

  • 1. Precision medicine advancements in glioblastoma: A systematic review.
    Iyer K; Saini S; Bhadra S; Kulavi S; Bandyopadhyay J
    Biomedicine (Taipei); 2023; 13(2):1-13. PubMed ID: 37937301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
    Nozhat Z; Heydarzadeh S; Shahriari-Khalaji M; Wang S; Iqbal MZ; Kong X
    Biomater Sci; 2023 Jun; 11(12):4094-4131. PubMed ID: 37073998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeted therapy: A new avenue in glioblastoma treatment.
    El Atat O; Naser R; Abdelkhalek M; Habib RA; El Sibai M
    Oncol Lett; 2023 Feb; 25(2):46. PubMed ID: 36644133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma.
    Bauman MMJ; Bouchal SM; Monie DD; Aibaidula A; Singh R; Parney IF
    Neurosurg Focus; 2022 Dec; 53(6):E14. PubMed ID: 36455271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
    Verdugo E; Puerto I; Medina MÁ
    Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
    Chen Y; Gao Z; Wang B; Xu R
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):516. PubMed ID: 27557118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme.
    Mishra VS; Kumar N; Raza M; Sehrawat S
    Oncotarget; 2020 Dec; 11(51):4754-4769. PubMed ID: 33473259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology.
    Sesé B; Ensenyat-Mendez M; Iñiguez S; Llinàs-Arias P; Marzese DM
    Clin Epigenetics; 2021 Jul; 13(1):150. PubMed ID: 34332627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advancements and Strategies for Overcoming the Blood-Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma.
    Tincu Iurciuc CE; Andrițoiu CV; Popa M; Ochiuz L
    Polymers (Basel); 2023 Oct; 15(19):. PubMed ID: 37836018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
    Lu VM; O'Connor KP; Shah AH; Eichberg DG; Luther EM; Komotar RJ; Ivan ME
    J Neurooncol; 2020 Jun; 148(2):221-229. PubMed ID: 32385699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.